Historical Ibogaine Media

Historical Ibogaine Media & Press Archives

This is not a complete archive of ibogaine-related pieces from the 90s, it represents part of a collection of materials which were not accessible on the internet previously. In particular it focuses on the FDA and NIDA’s involvement during a period of time when ibogaine testing on human subjects had been approved by the FDA and permission granted to Dr. Deborah Mash and the University of Miami to proceed with clinical trials. Plus, also, it contains EVEN MORE Dana Beal than ever before.

The clinical trials for ibogaine eventually ground to a halt when NIDA refused to provide further funding to pursue the necessary research and instead turned their focus and attention to the opioid-maintenance drug buprenorphine (branded and marketed as: Subutex and Suboxone).

Due to strong financial backing and lobbying by Reckitt Benckiser (the pharmaceutical company that developed buprenorphine), the Drug Addiction Treatment Act of 2000 (DATA 2000) was passed; it allowed physicians who received special training to prescribe Schedule III, IV and V narcotic drugs for drug treatment. Prior to this historic event, most individuals on opioid-maintenance programs were required to attend opioid-maintenance clinics and were subjected to the often dehumanizing conditions of current methadone-maintenance programs.

Within the United States buprenorphine was rescheduled to Schedule III, and approved for maintenance of opioid addiction in October of 2002. This allowed opioid-dependent individuals to simply pick up their prescriptions at any pharmacy, instead of being treated like cattle or prisoners of the state (a realistic assessment of what many methadone-maintenance programs have devolved into).

Ibogaine was kicked to the curb, and Americans received yet another highly-addictive — and highly profitable — opioid for use in substitution therapy. While buprenorphine represents a significant harm reduction victory, and policy improvement over methadone maintenance; when all is said and done, it’s Yet Another highly-addictive opioid maintenance drug that falls far short of a providing a “cure” or interruption of drug dependence.

 

Ibogaine: the 90s Mahn...

Ibogaine: the 90s Mahn…

 

ACT UP Pickets CASA for Ibogaine Treatment on Demand 10-1992
 Hallucinogen Being Studied as Treatment for Addiction 11-1992
 Deborah Mash Prepares to do First Human Trials in US of African Hallucinogenic Herb Ibogaine 11-1992
 Addiction and Obsession 11-1992
 Time in the Joint For Selling Weed 01-1993
 Gonzo, But Not Forgotten 01-1993
 NIDA Commences Animal Testing on Ibogaine 01-1993
 Three NIDA research grants available 04-1993
 Ibogaine Found Toxic in Lab Tests 07-1993
 Drug Addiction: New Therapies, Old Policies (Lancet) 07-1993
 The Mystery of Ibogaine: can an African Psychedelic Cure Addiction? 07-1993
 West African Drug Approved For Test As Cure For Addiction 08-1993
 Human Trials to Begin on Ibogaine 08-1993
 FDA Urged to Approve Ibogaine 08-1993
 The Ibogaine Connection (Day One – ABC Transcript) 08-1993
 FDA meets with NIDA to discuss Ibogaine 08-1993
 FDA Advisers OK Human Testing Of Ibogaine 08-1993
 UM Is Ready To Test Ibogaine On Humans 08-1993
 Ibogaine – Crack Substitute Cited 08-1993
 A Psychedelic Trip to the End of Addiction 08-1993
 Ibogaine Studies begin at University of Miami 08-1993
 Safety tests proposed for anti-cocaine medicine: ibogaine 08-1993
 FDA Approves Miami Researchers’ Hallucinogen Experiment On Humans 08-1993
 Human Testing of Hallucinogen Backed 08-1993
 FDA’s Drug Abuse Advisory Panel Declines To Back A General Policy Saying Ibogaine Is Safe 08-1993
 Hallucinogenic Drug Ibogaine Can Halt User’s Desire To Take Heroin 09-1993
 Bizarre Drug Tested in the Hope of Helping Drug Addicts 10-1993
 Researchers have recently begun testing the African rain-forest drug ibogaine 10-1993
 Researchers Say 1 Drug May Cure Other Addictions 11-1993
 African Root Studied As Addiction Treatment 11-1993
 Hallucinogenic Herb May Help Drug Addicts 11-1993
 A Drug To Fight Drugs 03-1994
 New Drug Offers Hope For Curing Addiction; Testing Hits A Snag 03-1994
 Clinton’s Anti-Drug Budget Is Just Old Wine In New Bottles 03-1994
 The Psychedelic Cure 04-1994
 Heroin and Hope at the White Hotel 05-1994
Print Friendly

Comments are closed